News
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
3d
Investing News Network on MSNBird Flu Vaccine Stocks: 8 Companies Developing H5N1 VaccinesLife science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 ...
Robert F. Kennedy Jr. continues his anti-vax crusade by cancelling million-dollar bird flu vaccine deal with Moderna.
The bird flu virus remains a wild card that continues to threaten U.S. poultry and egg supplies while upping the ante with risk to human health.
The U.S. approved a new COVID-19 vaccine made by ... funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study ...
test and license vaccines for flu subtypes that could trigger future pandemics, including the dangerous H5N1 bird flu virus. The first COVID-19 case was reported in the United States on Jan. 20 ...
First used for the Covid vaccines made by Pfizer-BioNTech ... we concluded that continued investment in Moderna’s H5N1 mRNA vaccine was not scientifically or ethically justifiable.” ...
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...
"After a rigorous review, we concluded that continued investment in Moderna’s H5N1 mRNA vaccine was ... Jr. announced earlier this week that COVID-19 vaccines would be removed from the federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results